First Trust Nasdaq Pharmaceuticals ETF
ETFYour view on FTXH
First Trust Nasdaq Pharmaceuticals ETF
ETFFirst TrustSentiment
AUM (USD)
$1.04B
Expense Ratio
0.6%
Holdings
49
Sentiment
Overview for First Trust Nasdaq Pharmaceuticals ETF
- Fund Type
- ETF
- Fund Issuer
- First Trust
- Asset Class
- Sector Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- September 20, 2016
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- First Trust
- Asset Class
- Sector Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- September 20, 2016
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- First Trust
- Asset Class
- Sector Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- September 20, 2016
- Domicile
- US
About this fund
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals …
FTXH Stock Price
Key Facts
Sector EquityExpense Ratio
0.6%
AUM
$1.04B
Fund Details
Expense Ratio
0.6%
Assets Under Management
$1.04B
NAV
$40.41 USD
Holdings
49
Average Volume
561.7K
Inception Date
September 20, 2016
Asset Class
Sector Equity
Fund Issuer
First Trust
Domicile
US
ISIN
US33738R8372
CUSIP
33738R837
NAV Currency
USD
Expense Ratio
0.6%
Assets Under Management
$1.04B
NAV
$40.41 USD
Holdings
49
Average Volume
561.7K
Inception Date
September 20, 2016
Asset Class
Sector Equity
Fund Issuer
First Trust
Domicile
US
ISIN
US33738R8372
CUSIP
33738R837
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.